• Targeting the $160 billion U.S. hotel industry
• Targeting the $100 billion U.S. vacation rental industry
• Proprietary InsurTech Platform

InsuraGuest Inc. is a SaaS (Software-as-a-Service) company utilizing its proprietary flagship InsurTech software platform to provide specialized insurance products to end users in the business-to-business (B2B) and business-to-consumer (B2C) markets. The company’s first focus is on the B2B hotels and vacation rentals sectors, where its API integrates with the clients’ property management systems to offer guests a specialized guest protection policy. The platform and policy combination “InsurTech” product helps transfer the exposure to liability away from the client/property while guests benefit from potential accident and loss coverage during their stay.

InsuraGuest’s platform is currently capable of integrating with approximately 70 different hotel and vacation rental property management systems, giving it access to roughly 40,000 properties worldwide.

The company continues to pursue expansion opportunities and recently signed a Letter of Intent with a master general agent in the United Kingdom and Europe to distribute its platform and products to hotel and vacation rental markets in those regions, as well as plans to expand to Asia in 2020.

Protecting Guests, Enhancing Customer Experience

InsuraGuest is the first line of defense for both the property and the guest.

InsuraGuest is purchased by the hotel or vacation rental “property,” which offers the policy to each registered guest and its occupants for an additional fee. The specialized policy affords coverage for theft of personal property while in the hotel, as well as accidental medical expense and accidental death and dismemberment, up to the policy limits of $2,500 to $50,000.

Market Opportunity

The U.S. hotel industry generated more than $218 billion in annual revenues in 2018, an increase of $10 billion from the previous year, according to STR’s 2019 HOST Almanac. The European market is more than double the size of the U.S. market. According to Oxford Economics, there were 6.4 billion nights stayed in the world, with 2.6 billion hotel nights in Asia, 2.8 billion nights stayed in Europe, and 1.1 billion nights in the United States. Additionally, $100 billion was spent on vacation rentals in the United State alone, where there are approximately 4.5 million second homes are being managed by a third-party rental company.

With distribution in Europe and the United States, InsuraGuest’s demographics combined will total 3.9 billion nights stayed, and will more than double its vacation rental opportunities.

Within this burgeoning, high-demand industry is risk of liability to guest injury. For example, gym injuries are among the top five most common hotel accidents. Without proper hedges in place, the property may be liable in a personal injury claim or lawsuit.

Though the potential for accidents, slip and falls and mishaps can be widespread, it can be covered under the InsuraGuest Specialized Guest Protection Policy to provide guests a worry-free and enjoyable stay that potentially increases loyalty for the property.

Business Highlights

• Targeting hotels and vacation rentals, a multi-billion-dollar industry
• Providing the first line of defense in case of accident, loss or death
• Expanding distribution reach with footing in European hotel and vacation rental markets
• Expansion into Asia by 2020

Executive Team

Douglas Anderson, Chairman & Chief Executive Officer
Douglas Anderson has been a businessman in the real estate industry for nearly 30 years. His business expertise includes master planning and development implementation for larger-scale resorts, business parks and commercial developments across the USA and two provinces in Canada. His business endeavors include the founding of the 7th larger private equity fund in America focusing on multifamily and senior care (ROC Fund/Bridge IPG Fund). He serves as chairman/founder of a golf and winter sports ski holding company with operations in four major east coast markets and British Columbia, Canada.

Anderson earned a BS undergraduate degree in Consumer Studies with an emphasis in Architecture as an undergraduate at the University of Utah. He subsequently earned his Master’s in Business Administration. He also attended a three-year OPM Program a postgraduate business education at Harvard Business School in Boston. Anderson is an avid skier and outdoor enthusiast.

Charles James Cayias, President & Director
Charles James Cayias is also the president and owner of Charles James Cayias Insurance Inc. He is a third-generation insurance professional whose creativity and artistic vision have enabled him to establish a full-service agency combined with the personal service each client deserves. His outstanding people skills, honesty, integrity and fairness are evident by his loyal and growing clientele, the majority of which are referrals who become long-time customers and friends.

Cayias began his insurance career in the early 1970s and has been licensed since 1977. He is licensed in all 50 states and specializes in niche programs. He has extensive expertise in all aspects of the insurance industry including commercial insurance, employee benefits, workers’ compensation, professional liability, risk management and bonding.

Christopher J. Panos Vice President & Director
Christopher J. Panos is a highly competitive sales professional with over 15 years of territory manager sales experience and an award-winning record of achievements. He is exceptionally well organized with a proven work history that demonstrates self-discipline, superb communication skills, and the initiative to achieve both personal and corporate goals. Panos is successful in building relationships with a large network of industry professionals in order to grow and maintain new and existing business, exceed new sales objectives and provide in-depth product training to authorized dealers and sales personnel.

Alexander Walker III ESQ, Corporate Counsel & Director
Alexander Walker III ESQ has served as director of the company since September of 2018. He also has served as counsel to the company since July of 2018. Walker is an attorney and has been a member of the Utah Bar Association since 1987 and a member of the Nevada State Bar since 2003. His practice has involved general business litigation, in both federal and state courts, and transactional work, including securities offerings and registration, corporate formation and periodic reporting compliance. Walker has provided legal services to emerging businesses throughout his carrier and at times has served as an officer and board member as well as legal counsel public companies. His duties as legal counsel for a public company engaged in the business of ownership and operation of coal-producing properties in the western United States included oversight of corporate-related legal matters including securities reporting, corporate compliance, federal and state mining regulation, and employment law oversight. He also has served as the chair of the Mining Committee of the Energy, Natural Resources and Environmental Law Section of the Utah State Bar, a member of the board of directors of the South East Utah Energy Producers Association, the co-chair of the board of the Western Energy Training Center, a board member of the Utah Supreme Court Committee to Review the ABA Recommendations Regarding the Office of Professional Conduct, and a board member of the University of Utah Crimson Club.

Roger Bloss, Corporate Consultant & Board Advisor
Roger Bloss joined InsuraGuest in August of 2019 to advise the company and its board on hotel transactions, contributing his knowledge from more than 40 years in the hospitality industry. Bloss previously served in executive positions with several major hotel franchise companies and in 1996 founded Vantage Hospitality Group hotel brands. Under his leadership, Vantage became a Top 10 global hotel company and made the Inc. 500/5000 list of Americas’ fastest-growing private companies for eight straight years. Bloss was named Lodging Magazine’s “Innovator of the Year” in 2006 and 2010, and in 2009 earned a spot on HSMAI’s “Top 25 Extraordinary Minds in Sales and Marketing.” Bloss joined Red Lion Hotels Corporation (RLHC) in September 2016 in conjunction with the acquisition of Vantage.

For more information, visit the company’s website at www.InsuraGuest.com

NOTE TO INVESTORS: The latest news and updates relating to InsuraGuest are available in the company’s newsroom at http://ibn.fm/InsuraGuest

• The company partnered with an inventor to obtain reissue patent US RE38,137, titled ‘Programmable Multiple Company Credit Card System’, issued in 2003 with 35 claims
• The original patent application for the novel technology was filed in September 1995, with patent protection first granted in U.S. Patent 5,859,419, issued in January 1999
• The company has filed a lawsuit against Apple, accusing the tech giant of unauthorized manufacture, use, offer for sale, sale and/or import of products that embody the inventions of US RE38,137

New York City-based intellectual property (IP) asset management company Quest Patent Research Corp. (OTCQB: QPRC) is fully committed to supporting individual inventors and small companies protect and monetize their innovations by partnering with them in prosecuting patents, identifying monetization opportunities and protecting them from patent infringement or IP theft. Operating through majority-owned and controlled subsidiaries, Quest Patent Research’s commitment is clearly illustrated by a recent case involving a universal financial data system technology currently in its portfolio and which Quest maintains has been infringed by Apple Inc. (NASDAQ: AAPL).

In 2000, the company partnered with the named inventor of U.S. patent 5,859,419, Silicon Valley engineer Sol H. Wynn, currently Sol M. Li – a hardware and firmware engineer with more than 30 years of experience in design and architecture, training junior engineers and technicians, digital electronic theory and its applications. He holds five U.S. Patents to directed to several of his technological innovations as well as international patents in China, Taiwan and India. With the help of Quest, a reissue application was filed in 2001 and an additional 22 claims were granted in 2003.

According to the specification of the patent, the invention disclosed in the patent “relates generally to financial data systems. More particularly, the invention relates to methods and apparatus for a universal financial data system, part of which advantageously serves as a highly portable cash substitute that is also capable of electronically compiling, storing and retrieving data related to multitudes of financial accounts and transactions in real time as the transactions occur.”

Lawsuit Against Apple

On April 12, 2019, Quest NetTech filed a lawsuit against Apple Inc. alleging willful and deliberate infringement of US RE38,137.

As per the complaint filed with the court, the accused devices include “electronic devices such as, but not limited to the iPhone 6 (hereinafter the “Accused Devices”). The Accused Devices, together with Apple’s software components such as, but not limited to, Apple Pay, iOS 8, iOS 9, and/or iOS 10 are configured to interact with Apple’s servers which provide the Apple Pay service, among other services provided by Apple and utilized by Apple’s customers when operating the Accused Devices. The complaint also states that “NetTech has not licensed or otherwise authorized Apple to make, use, offer for sale, sell, or import any Accused Devices and/or products that embody the inventions of the RE38,137 Patent.” The case is pending in the U.S. District Court for the Eastern District of Texas; Case No. 2:19-cv-00118-JRG.

According to Quest Patent Research, this action further demonstrates the company’s commitment to helping owners monetize compelling IP, as well as its recognition of forward-thinking technology, given that the products accused in the lawsuit significantly post-date the patented invention.

Currently owning, controlling and managing over 115 patents across 11 intellectual property portfolios, Quest Patent Research specializes in mature and emerging technologies and is dedicated to providing IP asset owners and stakeholders the opportunity to participate across a broad portfolio of dynamic assets in the intellectual property space.

For more information, visit the company’s website at www.QPRC.com

NOTE TO INVESTORS: The latest news and updates relating to QPRC are available in the company’s newsroom at http://ibn.fm/QPRC

• As the United States has emerged from the most recent economic recession during the past decade, travel and tourism-related industries have bloomed to historic levels of activity
• InsuraGuest has developed a proprietary InsurTech software platform that delivers a specialized insurance policy to hotels and vacation rental properties, which covers the guest during their stay.
• The insurance provides coverage for guest in the form of theft recovery, accidental medical expenses and accidental death and dismemberment
• InsuraGuest recently announced an LOI that extends its InsurTech platform and insurance products from the United States to Europe and the United Kingdom
• Europe’s hospitality stay market is more than double the market size in the United States, indicating room for great potential in serving hotel and vacation rental guests with the InsurTech insurance platform

Salt Lake City-based SaaS provider InsuraGuest recently announced a landmark LOI for the company that opens the doors to the United Kingdom’s and Europe’s hotel and vacation rental markets for its proprietary InsurTech insurance platform.

The platform’s API already works with about 70 different computerized hotel and vacation rental property management systems. The InsuraGuest InsurTech software delivers specialized guest protection policies, helping member properties transfer their exposure to liability (http://ibn.fm/pmm8Z).

The coverage, unlike travelers insurance, is a specialized policy that provides a first line of defense for both the hotel or vacation rental property and the travelers during their stays, with a potential of up to 40,000 different properties, and is purchased by the hotel property and then included with each guest’s folio charges for the stay. The policy provides coverage for theft of personal property, accidental medical expenses, and accidental death and dismemberment.

“We are excited to be expanding our distribution into Europe. The European market is more than twice the size of the U.S.,” InsuraGuest Chairman and CEO Douglas Anderson stated in a news release about the LOI (http://ibn.fm/tTbaa). “Last year there were 2.8 billion hotel nights stayed in Europe compared to 1.1 billion in the US. Additionally, $100 billion was spent on vacation rentals.”

A decade after the United States’ travel industry stepped from the shadows of a significant economic recession and shook hands with numerous emerging markets around the globe, the travel, vacation rental, and hotel industries are experiencing historic levels of consumer demand. Technological innovations like InsuraGuest have fueled the demand, energizing worldwide wanderlust by enabling ride-hailing services, alt-finance fluidity, shared selfie “wish you were here” moments and an array of accommodations options relatively easy to engage from half a world away.

In the United States alone, hotel gross bookings grew from $116 billion to $185 billion between 2009 and 2017, according to Deloitte (http://ibn.fm/nirXt). Last year, the travel and hospitality industries’ revenues were expected to top $500 billion, according to the company. While the industry insights firm anticipates the growth trend may slow in the near future, travel market segments are still expected to remain healthy.

“With distribution in Europe and the US, our demographics combined will total 3.9 billion nights stayed,” Anderson stated.

Online claim management is easy and timely, and it is available 24-hour a day through the company’s dashboard.

For more information, visit the company’s website at www.InsuraGuest.com

• New privacy laws in California place SRAX ahead of the competition
• Privacy has always been a consumer right for SRAX
• Building a reliable, opted-in consumer dataset has long-term, recurring revenue potential for SRAX

SRAX Inc. (NASDAQ: SRAX), a digital marketing and consumer data management technology company, has developed a consumer-managed data marketplace where people can own and earn from their data. As new privacy laws come into play in California, Los Angeles-based SRAX is already ahead of the competition.

BIGtoken, built by SRAX, offers a secure and transparent environment for consumers to own and earn from their data. Long before California law makers were writing legislation that valued the privacy of individuals over the agenda of big players (i.e. Facebook, Google, Amazon), SRAX was putting the consumer in the driver’s seat. Founded in 2010, the company has sought from the beginning to provide highly valued, consumer-powered data that reveals brands’ core consumers. By providing the consumer with essential key control, the company has unlocked the true value of data.

While other companies are adjusting budgets to cover the cost of compliancy to a new California law by January 1, 2020, BIGtoken has already sidestepped the legal data issue because it requests users’ permission for data sharing when those users initially sign up for the platform. BIGtoken puts control in the hands of the consumer by providing the right to privacy, awareness and choice from the get-go (http://ibn.fm/KG5zt). Once users sign up, they are able to determine and make decisions on how much of their information is shared and to whom. For SRAX, privacy has always been a right.

Doing the right thing from day one has placed SRAX a step ahead in the industry. Competitors in digital marketing and consumer data management will be spending up to $55 billion to comply with the California Consumer Privacy Act (CCPA) (http://ibn.fm/LtGNZ). The bill gives California residents the right to be informed about how companies gather and use their data, an ideal that is an integral component of BIGtoken’s core mission. BIGtoken has been building consumers’ trust, resulting in an increase of consumer opted-in data made available to brands, making that data far more valuable than information collected through data mining.

SRAX is building reliable, opted-in consumer data set that will have a long-term recurring revenue stream. As consumers become more aware of the value of their data, they naturally expect to be compensated for it. The larger social media platforms such as Facebook, Twitter, and Snapchat are experiencing consumer backlash as questions are being asked and more privacy laws are going into effect.

The CCPA appears to be only the beginning as consumers become more aware of their data rights and demand more of those entrusted with it. Privacy laws at both the state and federal level will continue to change and impact the way marketers reach consumers. As consumers become more empowered and informed, SRAX will continue to meet their high expectations.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• Located in the Netherlands, Truverra Europe is already established in select European markets, providing an early foothold for Supreme Cannabis
• Supreme Cannabis’ investment vehicle, Supreme Heights, provides European upstarts with access to capital, proven expertise and tools

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a company dedicated to growing the world’s best cannabis and becoming a leader in the global industry, is creating inroads into Europe’s cannabis industry through its various subsidiaries. The company is taking an aggressive approach to secure its position in Europe’s rapidly increasing cannabis market, a market worth an estimated $318 million in 2018, which is expected to grow more than 400 percent through 2023 (http://ibn.fm/oMWSS). SPRWF subsidiary, Truverra and investment vehicle, Supreme Heights are primed and ready to take advantage of Europe’s rapidly growing cannabis market.

The recently acquired Truverra Inc., a global medicinal CBD brand, provides Supreme Cannabis with additional expansion opportunity in Europe. Truverra’s wholly owned European subsidiary, Truverra Europe, is located in the Netherlands and is already established in select European markets (http://ibn.fm/1VuEV). Truverra uses clean, pure CBD oil drawn from 100 percent organic, European hemp strains. The oil is then combined with natural ingredients to create the exceptional Truverra-branded products that consumers in the United Kingdom have come to expect.

Supreme Cannabis’ London-based investment platform, Supreme Heights (http://ibn.fm/IKsLp), is also penetrating the cannabis market in Europe. The launch of Supreme Heights provided promising European upstarts in the CBD market access to SPRWF’s leadership, comprehension of regulations, premium-product commercialization, marketing, and much more. Patrick Morton, co-founder of Cannabis Invest UK, was made CEO of Supreme Heights, providing the investment platform with his already established, expansive network of local and global cannabis and CBD companies and giving the new platform the jumpstart it needs in collecting potential investments.

In addition, Supreme’s dynamic brand activity has drawn investor attention. The company was recently the subject of an article by CFN Media Group detailing SPRWF’s savvy penetration of the European cannabis market. The article noted that Supreme Cannabis is building its cannabis portfolio at a “blistering pace” and described Europe’s “larger opportunity” for cannabis companies with its population of 513 million people (as compared to only 37 million in Canada). The article added that only five countries of the 28 country members of the European Union ban cannabis.

The CFN analysis (http://ibn.fm/ZMAxt) finds that “nothing speaks more clearly to the ability to scale than Supreme this month providing revenue guidance for the next year in the range of $150 million to $180 million.” The article adds that “the robust growth is owed to management’s ability to make prescient moves to stay in front of regulation changes in addition to operational excellence.” The launch of Supreme Heights provided the company with a gateway to investment in the European cannabis market.

For more information, visit the company’s website at www.Supreme.ca

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://ibn.fm/SPRWF

• Earth Science Tech focuses on researching and developing inventive hemp extracts
• The company has three unique, wholly owned subsidiaries
• ETST recently reported a significant increase in revenue and gross profit

A science-based biotech company, Earth Science Tech Inc. (OTCQB: ETST) operates in the hemp-derived cannabinoids, nutraceuticals, pharmaceuticals, medical-devices, and research and development (R&D) fields. The company focuses on researching and developing unique hemp extracts and making those extracts accessible globally. The company offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market.

Recently, Earth Science Tech reported a 36 percent revenue gain as well as a 90 percent increase in gross profit for the quarter ended June 30, 2019 (http://ibn.fm/ff5C8). Full-spectrum cannabinoids are propelling the company’s consistent sales. Of note for investors is that Earth Science Tech earlier reported product sales totaled $770,635 for fiscal year ending March 31, 2019. This represents a 66.4 percent increase as compared to the $463,108 recorded for the same period in 2018. At the same time, the company maintained an impressive gross profit total of $295,013 and a gross margin of 38.2 percent in 2019.

The company’s significant revenue success is due in no small part to its diverse array of subsidiaries. Headquartered in Doral, Florida, Earth Science Tech has three wholly owned subsidiaries: Earth Science Pharmaceutical Inc., Cannabis Therapeutics Inc., and Canadian subsidiary Canna Inno Laboratories Inc.

Earth Science Pharmaceutical concentrates on becoming an international leader in the development of low-cost, non-invasive diagnostic tools, medical devices, testing processes, and vaccines for STIs (sexually transmitted infections and/or diseases). The company is dedicated to developing pioneering medical devices and vaccines that will improve health worldwide, particularly for women. ETST’s first medical device is MSN-2, a home kit designed for the detection of STIs from a self-obtained gynecological specimen.

Earth Science Tech’s Cannabis Therapeutics subsidiary is an emerging biotech company invested in research and development to explore and harness the medicinal power of cannabidiol. Cannabis Therapeutics is positioned to become a world leader in cannabinoid R&D for a wide-ranging line of cannabinoid-based pharmaceuticals, nutraceuticals and other product solutions. The company’s initial projects are focused on developing treatments for breast and ovarian cancers.

The Canna Inno Laboratories subsidiary, a strategic Montreal-based company, is giving Earth Science Tech a foothold in Quebec. Canna Inno allows ETST access to Government of Canada funding, the first of which has recently been approved. This subsidiary will also enable the advancement of further product via grants offered to pharmaceutical innovators (http://ibn.fm/6xpLp).

Earth Science Tech’s high-grade, CBD-rich hemp oil is formulated using a broad array of innovative technologies. The process includes a super-critical extraction process (CO2), isolation and micron filtration. Super-critical extraction is a gentle approach and is the key method in the extraction of the company’s CBD (http://ibn.fm/MC36b).

Earth Science Tech markets a complete line of high-grade, hemp-CBD oils, hemp-CBD caps, and CBD pet oil products with its full-spectrum and pure CBD oils. The company’s CBD-rich hemp oil contains no synthetic cannabinoids and is not an isolate. Rather, the oil contains everything that is naturally occurring in the original industrial hemp plant. The company’s commercialized CBD-based product line, High Grade Full Spectrum Cannabinoids, provides seven distinct cannabinoids, and is formulated to maximize all the therapeutic benefits the industrial-hemp plant has to offer.

With a management team consisting of industry experts with decades of experience in the nutraceuticals, dietary-supplements and life-sciences fields, Earth Science Tech continues to innovate in the CBD space. The company offers investors a strong platform and exposure to multiple markets experiencing rapid growth. ETST is consistently executing on its strategic mission to expand its role as a leader in diverse market sectors.

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST

• The program focuses on the pursuit of reduced risk oral nicotine products that make use of Lexaria’s patented DehydraTECH drug delivery platform
• DehydraTECH has been studied extensively and both human/animal trials confirm its ability to enhance active ingredient absorption in digestible products
• The current research could contribute to the development of oral nicotine products that would usher in a new era of reduced-risk nicotine use

Global innovator in drug delivery platforms Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) provided an extensive update on advances in its research and development program with Altria Ventures Inc., an indirect wholly owned subsidiary of Altria Group, Inc (NYSE: MO). The collaboration focuses on the pursuit of reduced risk oral nicotine consumer products using the Lexaria-patented DehydraTECH technology.

Most of the work within the first phase of the collaborative project has either been completed or is significantly underway. Only one aspect of the project remains to commence imminently, according to a company press release issued on October 8, 2019 (http://ibn.fm/Czxkv).

The successful completion of the first phase of the program will be the first step in developing viable products with Lexaria’s DehydraTECH drug delivery platform. Under the terms and conditions of the agreement, Lexaria’s majority owned subsidiary Lexaria Nicotine LLC will see royalties being paid from any sold oral nicotine products, in the event of Altria deciding to use the technology in the U.S. or overseas.

Due to the advances in the program, the two partners have been thoroughly studying the process of oral nicotine administration. Lexaria Bioscience and Lexaria Nicotine CEO Chris Bunka said, “Lexaria strongly believes that, given the choice, many of the world’s one billion smokers would elect to experience their nicotine in a manner that does not rely on either smoking or vaping, and Lexaria can help enable these alternatives.”

Lexaria’s philosophy is that the oral administration of nicotine can provide a reduced-risk access to the substance, providing better health outcomes than standard combustible cigarettes.

The DehydraTECH technology is a vital component for product development. Human and animal clinical studies have demonstrated DehydraTECH’s ability to enhance bio-absorption and bioavailability of active compounds in oral administration products.

The technology has a wide scope of additional applications. DehydraTECH can improve taste, remove odor and bring down the time to onset in the case of delivering active ingredients within generally recognized as safe (GRAS) food ingredients. Because of its superior performance characteristics, the technology is also being used by the CBD industry. Research suggested that CBD absorption into human intestinal cells increased by 499 percent through the utilization of the DehydraTECH technology.

Similar results were observed in previous animal studies, suggesting a massive increase in absorption (811 percent) when comparison was made with a control group.

Lexaria has also completed several phases of collaborative study with the National Research Council in Canada (http://ibn.fm/UC2eZ). Several work programs were designed to evaluate and characterized the DehydraTECH technology utilizing nuclear magnetic resonance and other advanced methods of study such as DLS and Zeta Potential analysis.

Lexaria Bioscience is a global innovator in drug delivery platforms. It operates a licensed in-house research laboratory and the company also holds an impressive portfolio of 16 patents granted and over 60 patents pending.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

• Provides access through bank partners to secure online, safe and convenient banking services for businesses in the cash-intensive cannabis industry
• Founded by banking and payments industry veterans experienced in building and scaling businesses
• Partnered with numerous financial institutions to help cash-intensive businesses reduce financial and safety risk, and run their businesses more efficiently
• Deposits held at partner banks are FDIC-insured up to $250,000 per account

Dama Financial, through its bank partners, provides cannabis-related businesses (CRBs) access to transparent, sustainable banking and payment solutions. Using innovative technology, data and artificial intelligence, Dama exceeds the compliance and regulatory requirements for servicing CRBs, bringing legitimacy to the rapidly growing cannabis industry. Dama’s comprehensive and compliant financial framework offers CRBs the option to maintain cashless operations, reducing their exposure to security risks while improving their business efficiencies and operational focus.

Background

As successful fintech entrepreneurs, Dama’s founders have a proven track record of building companies that have removed the barriers that exclude unbanked categories from accessing the fundamental financial solutions necessary to thrive. During the past three years, Dama’s leadership team has turned its focus to addressing the challenges burdening the cannabis industry – the unbanked category of our time.

On behalf of its bank partners, Dama offers access to:

Dama Premier

• Schedule recurring or ad-hoc appointments for secure cash pick-ups and delivery via armored courier
• Monitor activity in real time via desktop or mobile or be notified of transaction alerts via email or text
• Send payments via electronic ACH, wire-transfer or check to approved payees
• Receive electronic funds from approved partners
• Transfer money quickly between Dama-managed accounts

CashToTax℠

• Schedule secure cash pick-ups and delivery via armored courier
• Monitor activity in real time via desktop or mobile or be notified of transaction alerts via email or text
• Send electronic tax payments to approved tax authorities
• Monitor account activity 24/7 with online and mobile access
• No minimum balance or account fees

PayMyWay℠

• Accept electronic retail payments using the secure PayMyWay℠ mobile application
• Customers can fund the app using a linked bank account or debit card at checkout with any PayMyWay merchant
• Funds settle to the merchant’s PayMyWay Merchant account
• Integrates seamlessly with any point-of-sale system

All Dama clients enjoy:

• FDIC insurance on deposits of up to $250,000 per account
• Dedicated Relationship Manager for account-related inquiries

Dama Financial is an agent of its partnering financial institutions and licensed money transmitters. Customers’ funds will be deposited into a custodial account maintained for the benefit of account holders at one or more FDIC-insured institutions. Fees, terms and conditions apply to depositing funds into and using an Account. Account Terms and Conditions and Fee Schedule are available upon registration to access the online application.

For more information, visit the company’s website at www.DamaFinancial.com

NOTE TO INVESTORS: The latest news and updates relating to Dama Financial are available in the company’s newsroom at http://ibn.fm/Dama

• VPR Brands focuses on the cannabis and nicotine industries
• The company is shifting initiatives toward cannabidiol (CBD)
• VPR Brands focuses on premier products and distribution in order to build sales and profits

CBD products in an array of forms continue to transform the marketplace, surpassing Kim Kardashian, Beyoncé, and veganism in search popularity according to Google data (http://ibn.fm/rpYXZ). CBD is on the rise as one of the most popular terms searched, as consumers are continually looking for unique, high-quality CBD products and the enterprises that manufacture and distribute them. The forecast calls for the CBD market to grow to an estimated $22 billion by 2022 (http://ibn.fm/mPFDs).

A technology holding company, VPR Brands LP (OTCQB: VPRB) is positioned at the juncture of the cannabis and nicotine industries and poised to take advantage of the steady growth of CBD popularity. The company’s assets include issued U.S. and Chinese patents for atomization-related products, including technology for medical marijuana vaporizers and electronic cigarette products and components. One of the most undervalued, unknown gems on the OTC Markets in the cannabis sector, VPRB additionally is involved in product development for up-and-coming innovations poised to disrupt in various markets.

Based in Fort Lauderdale, Florida, VPR Brands is shifting its emphasis toward CBD (cannabidiol) as it prepares to launch two new CBD brands websites: www.DrGoodHemp.com and www.CBDBrandDepot.com. With its strong strategy of continually adding quality products and distribution designed to grow sales, VPR’s increasing customer base portends well for its CBD initiatives as the company offers a diverse portfolio of innovative products.

VPR Brands nurtures brands by way of direct sales and licensing opportunities in the CBD vertical. The company’s in-house product development is a significant differentiator, allowing VPRB to expand its margins (http://ibn.fm/oOaoT). VPR’s flagship CBD line, GoldLine, provides a broad product portfolio with offerings that include pre-rolled joints, vape cartridges, edibles, CBD pens, and crumble as well as tinctures.

VPR Brands, with its astute management team leading the way, is well positioned to leverage this burgeoning market. The company’s diverse brand portfolio includes GoldLine, GoldLine Hemp, HoneyStick, Helium, Vaporin, and Vaporx. VPRB also has its Vapor Store Direct in Fort Lauderdale, which is one of the largest vaporizer and e-liquid wholesalers in the United States. Regarding CBD specifically, VPR Brands’ GoldLine is at the forefront of the market when it comes to pioneering safe, all-natural CBD-derived products.

VPR Brands’ emphasis on first-rate products, widespread distribution, and an engaged customer base offers ROI potential for investors looking to participate in CBD initiatives. By combining premium ingredients and extracts coupled with modern technology, the company’s GoldLine brand offers the ultimate selection of CBD and hemp-based products available in the marketplace.

Furthermore, VPR Brands knows how to efficiently market its product family for revenue growth and will bring this expertise to its CBD program. Of note is VPRB’s stellar performance. The company increased its Q1 2019 revenues roughly 31 percent year over year to $1.3 million. In addition, VPRB continues to maintain strong gross operating margins above 40 percent (http://ibn.fm/yFFmQ). Concerning its 2018 results, VPR Brands increased its full-year revenues to roughly $4.6 million while its full-year 2018 gross operating margins increased by close to 20 percent from 2017 to a margin of 41 percent in 2018 (http://ibn.fm/KoyoU).

As VPR Brands continues to concentrate on cannabis consumables and market-share growth, that upward trend will likely only increase. The company partners with leading global brands to elevate and accelerate its products into the vanguard of the industry. VPR Brands offers investors the opportunity for portfolio diversification with its dynamic suite of brands for the nicotine and CBD markets.

For more information, visit the company’s website at www.VPRBrands.com

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at http://ibn.fm/VPRB

• IONIC Brands Corp. is a west coast company which was established in 2015 as a supplier of recreational cannabis products such as cannabis oils and vaporizer products, including vape pens
• IONIC Brands Corp. achieved a year-over-year increase in revenue of over 377 percent, and it plans to expand into more states across the nation
• IONIC expects that, by early 2020, its products will be distributed through 318 stores in California and 225 stores in Oregon

IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) is a cannabis holding company supplying recreational cannabis products, with headquarters in Tacoma, Washington. The company’s cannabis products are currently sold in 685 stores across the U.S., and it is planning further expansion around the country. In addition to other states, IONIC plans to expand to at least 318 stores in California and 225 stores in Oregon by January 2020.

This company offers luxury brands in the premium space and is involved in the recreational cannabis market. IONIC Brands was founded in 2015 by a group of entrepreneurs who were interested in the cannabis market. The company now focuses on making small batch cannabis oils and various cannabis concentrates that are pure and therefore do not contain any additives, additional glycols or glycerin chemicals. The vision behind IONIC Brands was to create products for the upscale recreational cannabis market. The cannabis market is predicted to expand in the future, particularly as legislation continues to evolve.

IONIC Brands Corp. has shown profits and increasing revenue over the last three years, and it aims to continue riding the strong performance of the cannabis space moving forward. Demand for concentrates is projected to increase in the future, and IONIC Brands believes that this provides an opportunity for growth.

The flagship product for IONIC is its vape pen line, which has done well in the marketplace, particularly in Washington State. This vaporizer product is currently ranked in the top 10 of such products in Washington State, which suggests that expansion into other states and distribution centers will likely be successful. Overall, vape sales grew by 93 percent in 2017 alone, and spending on edible cannabis products is projected to double from 2019 to 2022, reaching $4.1 billion.

IONIC Brands also has a certified clean program – which ensures that its products are clean in the sense that they pass states’ mandates for pesticide levels and safety. The company remains committed to ensuring safety and purity standards when producing its offerings.

The items and brands produced by IONIC include more than just the IONIC vaporizer pens; they also include Vuber technologies, Zoots edibles and Vegas M Stick vaporizer pens. The increasing popularity of these products is expected to lead to market growth for IONIC, which seeks to become a marketplace leader in the premium recreational cannabis industry.

IONIC Brands expects to add to its profits in the coming months, with revenue predicted to hit $46 million in 2019. Second quarter earnings for IONIC Brands showed an increase of over 377 percent year-over-year (http://ibn.fm/08vL3). The company leverages an aggressive growth strategy, is vertically integrated and has diversified its product range.

IONIC Brands has plans to be a national leader in the recreational cannabis space for both vaporizer products and edibles, and it also has ambitious expansion plans for the coming years and is interested in looking into markets outside of its current distribution network.

The company also made strides by recently acquiring patents for cannabinoid-infused coffee. With the popularity of coffee and cannabis, this is expected to be a good combination and investment for IONIC Brands in the coming years.

IONIC Brands’ portfolio includes ZOOTS, an edibles company that is also based in Washington, as well as Vegas Valley Growers based in Nevada and Vegas M stick pens. Through the Vegas M stick pens brand, IONIC plans to expand further into Nevada and Oregon; the products are currently distributed in Washington.

The market growth of the company and rising profits suggests that IONIC Brands will be able to successfully expand nationwide and further distribute its products throughout the nation. IONIC vape pen sales rose from just over $2 million in 2016 to $9.9 million in 2018, and, with the increasing popularity of vape pens, the trend seems likely to continue.

For more information, visit the company’s website at www.IONIC.social

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at http://ibn.fm/IONKF